Plasmodium falciparum malaria vaccines in development
- PMID: 18324891
- DOI: 10.1586/14760584.7.2.223
Plasmodium falciparum malaria vaccines in development
Abstract
The development and implementation of a malaria vaccine would constitute a major breakthrough for global health. Recently, numerous new candidates have entered clinical testing, following strategies that are as diverse as the malaria cycle is complex. While promising results have been obtained, some candidate vaccines have not fulfilled expectations. The challenges are not merely scientific; further progresses will require the development of competent investigator networks, partnerships between academics, industry and funding agencies, and continuous political commitment. In this review, we present the developmental status of all malaria vaccine candidates that are currently in human clinical testing against Plasmodium falciparum, as well as selected malaria vaccine candidates at preclinical development stage, and discuss the main challenges facing the field of malaria vaccine development.
Similar articles
-
Malaria vaccines in development.Expert Opin Emerg Drugs. 2005 Aug;10(3):489-503. doi: 10.1517/14728214.10.3.489. Expert Opin Emerg Drugs. 2005. PMID: 16083325 Review.
-
The development of malaria vaccines: SPf66--what next?Schweiz Med Wochenschr. 1996 Jul 9;126(27-28):1210-5. Schweiz Med Wochenschr. 1996. PMID: 8766632
-
Malaria vaccine: a current perspective.J Vector Borne Dis. 2008 Mar;45(1):1-20. J Vector Borne Dis. 2008. PMID: 18399312 Review.
-
Advances in vaccine development against the pre-erythrocytic stage of Plasmodium falciparum malaria.Expert Rev Vaccines. 2006 Feb;5(1):81-93. doi: 10.1586/14760584.5.1.81. Expert Rev Vaccines. 2006. PMID: 16451110 Review.
-
[The malaria vaccine candidate RTS,S/AS is in phase III clinical trials].Ann Pharm Fr. 2010 Nov;68(6):370-9. doi: 10.1016/j.pharma.2010.07.002. Epub 2010 Oct 13. Ann Pharm Fr. 2010. PMID: 21073995 Review. French.
Cited by
-
A recombinant Plasmodium vivax apical membrane antigen-1 to detect human infection in Iran.Korean J Parasitol. 2012 Mar;50(1):15-21. doi: 10.3347/kjp.2012.50.1.15. Epub 2012 Mar 6. Korean J Parasitol. 2012. PMID: 22451729 Free PMC article.
-
The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections.PLoS Pathog. 2010 May 20;6(5):e1000912. doi: 10.1371/journal.ppat.1000912. PLoS Pathog. 2010. PMID: 20502681 Free PMC article.
-
Evaluation of three medicinal plant extracts against Plasmodium falciparum and selected microganisms.Afr J Tradit Complement Altern Med. 2014 Jun 4;11(4):142-6. doi: 10.4314/ajtcam.v11i4.22. eCollection 2014. Afr J Tradit Complement Altern Med. 2014. PMID: 25392594 Free PMC article.
-
Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assay.Clin Vaccine Immunol. 2009 Jul;16(7):963-8. doi: 10.1128/CVI.00042-09. Epub 2009 May 13. Clin Vaccine Immunol. 2009. PMID: 19439523 Free PMC article.
-
Plasmodium falciparum immunodominant IgG epitopes in subclinical malaria.Sci Rep. 2020 Jun 10;10(1):9398. doi: 10.1038/s41598-020-66384-0. Sci Rep. 2020. PMID: 32523082 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical